|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A01K 67/027 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| C07K 16/40 | (2006.01) | ||
| C07K 16/46 | (2006.01) |
| (11) | Number of the document | 2858487 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13710268.7 |
| Date of filing the European patent application | 2013-03-07 | |
| (97) | Date of publication of the European application | 2015-04-15 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-23 |
| (46) | Date of publication of the claims translation | 2019-12-27 |
| (86) | Number | PCT/US2013/029624 |
| Date | 2013-03-07 |
| (87) | Number | WO 2013/187953 |
| Date | 2013-12-19 |
| (30) | Number | Date | Country code |
| 201261658466 P | 2012-06-12 | US | |
| 201261663131 P | 2012-06-22 | US |
| (72) |
MACDONALD, Lynn, US
MCWHIRTHER, John, US
TU, Naxin, US
STEVENS, Sean, US
MURPHY, Andrew, J., US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Gyvūnai, išskyrus žmogų, kurie yra humanizuoti ir turi redukuotą imunoglobulino sunkiosios grandinės lokusą |
| HUMANIZED NON-HUMAN ANIMALS WITH RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN LOCI |
| Payment date | Validity (years) | Amount | |
| 2025-02-18 | 13 | 289.00 EUR |
| 2026-03-07 |